Burka J F, Saad M H
Br J Pharmacol. 1984 Nov;83(3):645-55. doi: 10.1111/j.1476-5381.1984.tb16218.x.
Isoprenaline, vasoactive intestinal peptide (VIP), prostaglandin E2 (PGE2) and forskolin caused a dose-dependent relaxation of normal and ovalbumin-sensitized guinea-pig tracheal spirals and lung parenchymal strips in vitro. There was no difference in magnitude of relaxation or sensitivity to these relaxants between normal and sensitized tissues. The rank order of potency (concentration of each drug at which 50% of the maximum is obtained) for these relaxants on both trachea and parenchyma was VIP greater than isoprenaline greater than PGE2 greater than forskolin, although the parenchyma was more sensitive than the trachea. The rank order of efficacy of the drugs used in relaxing both the trachea and lung parenchyma was isoprenaline (10 microM) greater than forskolin (30 microM) greater than VIP (0.1 microM) greater than PGE2 (10 microM). PGE2 at concentrations greater than 1 microM sometimes contracted the lung strip. Pretreatment with indomethacin (8.5 microM), a cyclo-oxygenase inhibitor, reduced the resting tone of tracheal spirals, but did not significantly affect the tone of lung strips. Indomethacin-pretreatment did not affect drug-induced relaxations of either normal or sensitized tracheal spirals. However, both normal and sensitized indomethacin-pretreated lung strips relaxed significantly less (P less than 0.05) to isoprenaline, PGE2 and forskolin. Indomethacin-pretreatment did not affect sensitivity of normal and sensitized trachea or parenchyma to the relaxant drugs. All the relaxant drugs used stimulated adenylate cyclase activity in normal or sensitized lung parenchyma membrane preparations. The rank order of efficacy (maximal activation) was forskolin greater than isoprenaline = VIP greater than PGE2. There was no difference in response between normal and sensitized lungs. Adenylate cyclase activity of normal lung was stimulated as follows: forskolin (100 microM), 500.0 +/- 50.0%; isoprenaline (100 microM), 186.0 +/- 29.0%; VIP (10 microM), 213.0 +/- 19.0% and PGE2 (100 microM), 155.0 +/- 23.0% of basal activity. Similar values were obtained for sensitized lung parenchyma. Indomethacin-pretreatment did not significantly affect normal or sensitized lung adenylate cyclase stimulation by isoprenaline, VIP, forskolin or PGE2. It was concluded that: Immunological sensitization to ovalbumin does not induce hypoactivity of relaxant drug receptors and/or the adenylate cyclase system of the airway tissues of the guinea-pig. (b) There is an apparent lack of correlation between tissue relaxation in vitro and adenylate cyclase activity since the rank order of the efficacy of a range of relaxants was different for the two effects and furthermore indomethacin-treatment of airway tissues yielded differential results.
异丙肾上腺素、血管活性肠肽(VIP)、前列腺素E2(PGE2)和福斯高林在体外可引起正常和卵清蛋白致敏的豚鼠气管螺旋条和肺实质条呈剂量依赖性舒张。正常组织和致敏组织之间在舒张幅度或对这些舒张剂的敏感性方面没有差异。这些舒张剂对气管和实质的效价顺序(获得最大舒张50%时每种药物的浓度)为VIP>异丙肾上腺素>PGE2>福斯高林,尽管实质比气管更敏感。用于舒张气管和肺实质的药物的效能顺序为异丙肾上腺素(10μM)>福斯高林(30μM)>VIP(0.1μM)>PGE2(10μM)。浓度大于1μM的PGE2有时会使肺条收缩。用环氧化酶抑制剂吲哚美辛(8.5μM)预处理可降低气管螺旋条的静息张力,但对肺条的张力没有显著影响。吲哚美辛预处理不影响正常或致敏气管螺旋条的药物诱导舒张。然而,正常和致敏的经吲哚美辛预处理的肺条对异丙肾上腺素、PGE2和福斯高林的舒张作用均明显减弱(P<0.05)。吲哚美辛预处理不影响正常和致敏气管或实质对舒张药物的敏感性。所有使用的舒张药物均能刺激正常或致敏肺实质膜制剂中的腺苷酸环化酶活性。效能顺序(最大激活)为福斯高林>异丙肾上腺素 = VIP>PGE2。正常肺和致敏肺之间的反应没有差异。正常肺的腺苷酸环化酶活性受到如下刺激:福斯高林(100μM),基础活性的500.0±50.0%;异丙肾上腺素(100μM),基础活性的186.0±29.0%;VIP(10μM),基础活性的213.0±19.0%;PGE2(100μM),基础活性的155.0±23.0%。致敏肺实质也获得了类似的值。吲哚美辛预处理对异丙肾上腺素、VIP、福斯高林或PGE2刺激正常或致敏肺腺苷酸环化酶的作用没有显著影响。得出以下结论:(a)对卵清蛋白的免疫致敏不会诱导豚鼠气道组织中舒张药物受体和/或腺苷酸环化酶系统的活性降低。(b)体外组织舒张与腺苷酸环化酶活性之间明显缺乏相关性,因为一系列舒张剂的效能顺序在这两种效应中不同,此外,气道组织的吲哚美辛处理产生了不同的结果。